پێشبینی سەهمی Corcept Therapeutics (CORT)

دەربارەی ئەم کۆمپانیایە

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the development of drugs for the treatment of serious metabolic and psychiatric disorders. The company’s main product modifies the action of cortisol, also known as the “stress hormone,” by blocking cortisol’s binding to one of two known receptors—the type 2 glucocorticoid receptor.